Evaluation of protein absorption after ingesting an enteral diet - Evaluation of protein absorption after ingesting an enteral diet

CPCC Company Limited0 个研究点目标入组 16 人开始时间: 2022年10月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects taking steadily (not less than three times a week) in the following affecting foods; health-specific, functional, and health foods (mainly amino acids), with any difficulty in refraining from having those after the consent. (2) Subjects taking medicine steadily, owing to some kind of disease. (3) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. 4) Subjects with drug/alcohol/food allergy. 5) Subjects being under another clinical research with some kind of medicine or health food, or who partook in that within four weeks before this study, or planning to take part in other clinical researches after giving informed consent to participate in this study. (6) Subjects who donated a 200 mL of their whole blood and/or blood components within a month before this study. (7) Subjects who donated a 400 mL of their whole blood within the last three months to this study. (8) Subjects who will be collected over 1200 mL in total of their blood within the last twelve months, after adding the blood amounts planning to be sampled in this study. 9) At a point of the screening test, subjects having some kind of infection. 10) Others who have been determined as ineligible for participation in this study, judging from the principal/sub investigator.

发起方

CPCC Company Limited